Ovid Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
CEOJeremy Max Levin
CEOJeremy Max Levin
Employees23
Employees23
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees23
Employees23
OVID Key Statistics
Market cap21.96M
Market cap21.96M
Price-Earnings ratio-0.87
Price-Earnings ratio-0.87
Dividend yield—
Dividend yield—
Average volume338.31K
Average volume338.31K
High today$0.331
High today$0.331
Low today$0.2904
Low today$0.2904
Open price$0.294
Open price$0.294
Volume497.62K
Volume497.62K
52 Week high$3.41
52 Week high$3.41
52 Week low$0.2425
52 Week low$0.2425
OVID News
TipRanks 3d
Ovid Therapeutics reports Q1 EPS (14c), consensus (13c)Reports Q1 revenue $130,000, consensus $25,000. “We’re off to a strong start across our pipeline and programs in what will be a defining year for Ovid,” said Dr...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.